These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
663 related items for PubMed ID: 19176384
1. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro. Lissitzky JC, Parriaux D, Ristorcelli E, Vérine A, Lombardo D, Verrando P. Cancer Res; 2009 Feb 01; 69(3):802-9. PubMed ID: 19176384 [Abstract] [Full Text] [Related]
2. Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway. Choi JH, Chen CL, Poon SL, Wang HS, Leung PC. Endocr Relat Cancer; 2009 Mar 01; 16(1):179-88. PubMed ID: 19022848 [Abstract] [Full Text] [Related]
3. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). Fang Y, Olah ME. J Pharmacol Exp Ther; 2007 Sep 01; 322(3):1189-200. PubMed ID: 17565009 [Abstract] [Full Text] [Related]
4. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. Rangarajan S, Enserink JM, Kuiperij HB, de Rooij J, Price LS, Schwede F, Bos JL. J Cell Biol; 2003 Feb 17; 160(4):487-93. PubMed ID: 12578910 [Abstract] [Full Text] [Related]
5. Elevation of cyclic AMP in Jurkat T-cells provokes distinct transcriptional responses through the protein kinase A (PKA) and exchange protein activated by cyclic AMP (EPAC) pathways. Fuld S, Borland G, Yarwood SJ. Exp Cell Res; 2005 Sep 10; 309(1):161-73. PubMed ID: 15963501 [Abstract] [Full Text] [Related]
6. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J. Invest Ophthalmol Vis Sci; 2008 Feb 10; 49(2):497-504. PubMed ID: 18234991 [Abstract] [Full Text] [Related]
7. B cell receptor-induced growth arrest and apoptosis in WEHI-231 immature B lymphoma cells involve cyclic AMP and Epac proteins. Grandoch M, López de Jesús M, Oude Weernink PA, Weber AA, Jakobs KH, Schmidt M. Cell Signal; 2009 Apr 10; 21(4):609-21. PubMed ID: 19167486 [Abstract] [Full Text] [Related]
9. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K. Gutiérrez-Cañas I, Juarranz MG, Collado B, Rodríguez-Henche N, Chiloeches A, Prieto JC, Carmena MJ. Prostate; 2005 Apr 01; 63(1):44-55. PubMed ID: 15468165 [Abstract] [Full Text] [Related]
10. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs. Shah BH, Neithardt A, Chu DB, Shah FB, Catt KJ. J Cell Physiol; 2006 Jan 01; 206(1):47-57. PubMed ID: 15920762 [Abstract] [Full Text] [Related]
11. Epac- and Rap- independent ERK1/2 phosphorylation induced by Gs-coupled receptor stimulation in HEK293 cells. Norum JH, Dawood H, Mattingly RR, Sandnes D, Levy FO. FEBS Lett; 2007 Jan 09; 581(1):15-20. PubMed ID: 17174312 [Abstract] [Full Text] [Related]
13. Cooperation of Epac1/Rap1/Akt and PKA in prostaglandin E(2) -induced proliferation of human umbilical cord blood derived mesenchymal stem cells: involvement of c-Myc and VEGF expression. Jang MW, Yun SP, Park JH, Ryu JM, Lee JH, Han HJ. J Cell Physiol; 2012 Dec 09; 227(12):3756-67. PubMed ID: 22378492 [Abstract] [Full Text] [Related]
15. Beta-adrenergic receptor-mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a phosphatidylinositol 3-kinase dependent pathway refractory to the antiproliferative action of cyclic AMP. Colombo F, Gosselin H, El-Helou V, Calderone A. J Cell Physiol; 2003 May 09; 195(2):322-30. PubMed ID: 12652658 [Abstract] [Full Text] [Related]
16. A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Carie AE, Sebti SM. Oncogene; 2007 May 31; 26(26):3777-88. PubMed ID: 17260025 [Abstract] [Full Text] [Related]
19. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1. El Zein N, Badran B, Sariban E. J Leukoc Biol; 2008 Apr 31; 83(4):972-81. PubMed ID: 18174366 [Abstract] [Full Text] [Related]